The judicious allocation of money will allow ToolJet to drive innovation, hence fueling its aim to revolutionise software development and provide incomparable value to its ever-growing user base.

Tooljet, the open-source low-code platform for developers, said today that it has received funding from M12, Microsoft’s venture fund, and GitHub through the M12 GitHub Fund to help it reach the next level of growth. ToolJet is ready to enhance its strong staff with this infusion of resources by hiring top-tier expertise across multiple domains.

“We’re thrilled to have Microsoft and GitHub on board with us on this journey.” Their investment demonstrates the power of our platform, community, and mission to democratise software development by making it more accessible to everyone’, said ToolJet CEO Navaneeth Padanna Kalathil.

Using the power of open-source technology, ToolJet enables clients to seamlessly increase the platform’s capabilities by easily integrating JavaScript-based plugins, enabling limitless customization and extensibility. In an official statement, the firm stated that by leveraging the power of AI, it hopes to improve the intelligence of its platform, allowing developers to employ advanced algorithms and automation to further expedite their development workflows.

This strategic investment will enable ToolJet to accelerate innovation, fueling its aim to revolutionise software development and provide incomparable value to its ever-growing user base, according to the firm.

“We believe that low-code development is an important way for businesses to accelerate innovation, and we are committed to assisting ToolJet in their mission.” “Navaneeth and the Tooljet team impressed us with their approach to low-code enterprise app building through open source community engagement,” said Priyanka Mitra, Partner at M12 and co-founder of the M12 GitHub Fund.

ToolJet’s low-code architecture, founded in April 2021 by Navaneeth Padanna Kalathil, prioritises data privacy compliance, answering organisations’ growing concerns.